Moreover, cost effectiveness associated with these tests in terms of infrastructure and staff management coupled with growing global reverence of diabetes and cardiovascular diseases and rising market penetration rates of point of care diagnostic products in emergency departments and CICS are expected to drive market demand over the next six years Growing number of decentralized diagnostic facilities is a significant trend observed in this market.
Rise In prevalence of diseases with high unmet medical needs In terms of early diagnosis and treatment such as stroke, sepsis, hyperventilation and diabetes and reimbursement policies supporting decentralized tests are some of the actors responsible for this market trend. The hospital glucose testing market dominated the overall market in 2012, accounting for over 10% of the global revenue. Rising global prevalence of diabetes, high market penetration of handheld glucose monitoring devices and growing patient awareness levels in this segment are some of the factors attributing to its market share.
